Nadia Debbas

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.

The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics

Piroxicam-??-Cyclodextrin

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Coronary artery stents: a rapid systematic review and economic evaluation

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics

Amiodarone reduces transmural heterogeneity of repolarization in the human heart

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study

Modeling the human Na_v1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade

European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support

Hypertrophic Cardiomyopathy

Cyclodextrin-based pharmaceutics: past, present and future

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans

QT-interval prolongation inright precordial leads

Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels

A model for human ventricular tissue

Adenosine‐Sensitive Ventricular Tachycardia:

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Brugada Syndrome: Report of the Second Consensus Conference

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

Evidence for Functional Relevance of an Enhanced Expression of the Na ⁺ -Ca ²⁺ Exchanger in Failing Human Myocardium

Sudden Cardiac Death

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

Diurnal variation of the QT interval--influence of the autonomic nervous system.

Late Sudden Deaths after Repair of Tetralogy of Fallot:Electrocardiographic Findings Associated with Survival

Nitrendipine

Clinical Pharmacology of Piroxicam-??-Cyclodextrin

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population

Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Part 8: Adult Advanced Cardiovascular Life Support

Sodium/Calcium Exchange: Its Physiological Implications

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Adenosine and Supraventricular Tachycardia

Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderly

Clinical cardiac electrophysiologic evaluation of the positive inotropic agent, DPI 201–106

Stenting within a stent: Treatment for repeat in-stent restenosis in a venous graft

Effect of intravenous adenosine on human atrial and ventricular repolarisation

Comparison of elective Wiktor stent placement with conventional balloon angioplasty for new-onset lesions of the right coronary artery

A comparison of the haemodynamic effects of nifedipine, nisoldipine and nitrendipine in man

Determination of cardiac and plasma drug levels during long‐term amiodarone therapy

The effect of intravenous adenosine on atrial and ventricular repolarisation

The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone.

Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.

Class 1 antiarrhythmic drugs-Characteristic electrocardiographs differences when assessed by atrial and ventricular pacing